Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9831130rdf:typepubmed:Citationlld:pubmed
pubmed-article:9831130lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9831130lifeskim:mentionsumls-concept:C1517162lld:lifeskim
pubmed-article:9831130lifeskim:mentionsumls-concept:C0521447lld:lifeskim
pubmed-article:9831130lifeskim:mentionsumls-concept:C0032979lld:lifeskim
pubmed-article:9831130lifeskim:mentionsumls-concept:C1415587lld:lifeskim
pubmed-article:9831130lifeskim:mentionsumls-concept:C0086860lld:lifeskim
pubmed-article:9831130lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:9831130lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:9831130lifeskim:mentionsumls-concept:C0205369lld:lifeskim
pubmed-article:9831130lifeskim:mentionsumls-concept:C1519595lld:lifeskim
pubmed-article:9831130pubmed:issue12lld:pubmed
pubmed-article:9831130pubmed:dateCreated1999-2-5lld:pubmed
pubmed-article:9831130pubmed:abstractTextThe nonclassical MHC class I HLA-G antigen is expressed in cytotrophoblasts during pregnancy and may play a role in inhibiting lysis by maternal natural killer cells. HLA-G gene transcription was analyzed in human fetal liver of 6-8 wk of gestation, a development stage where classical HLA class I expression is very reduced. We demonstrated that HLA-G transcription is undetectable in these cells and we investigated the molecular mechanisms that control the lack of HLA-G gene transcription. We compared protein interactions of nuclear extracts from first trimester fetal livers, YT2C2-PR (HLA-G negative) and JEG-3 (HLA-G positive) cell lines to a 244-bp EcoR I/Hind III DNA region located 1.2 kb from the HLA-G gene, previously shown to direct HLA-G expression in transgenic mouse placenta. A strong specific C7-factor was specifically detected in first trimester fetal liver that could account for the inhibition of HLA-G transcription. Interaction of C7-factor and cell-specific factors previously detected in YT2C2 cell line (C5, C6) with two distinct regulatory regions identify this 244-bp EcoR I/Hind III fragment as a putative target for inhibition of HLA-G transcription.lld:pubmed
pubmed-article:9831130pubmed:languageenglld:pubmed
pubmed-article:9831130pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9831130pubmed:citationSubsetIMlld:pubmed
pubmed-article:9831130pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9831130pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9831130pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9831130pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9831130pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9831130pubmed:statusMEDLINElld:pubmed
pubmed-article:9831130pubmed:monthDeclld:pubmed
pubmed-article:9831130pubmed:issn0198-8859lld:pubmed
pubmed-article:9831130pubmed:authorpubmed-author:DaussetJJlld:pubmed
pubmed-article:9831130pubmed:authorpubmed-author:PaulPPlld:pubmed
pubmed-article:9831130pubmed:authorpubmed-author:MoreauPPlld:pubmed
pubmed-article:9831130pubmed:authorpubmed-author:CarosellaE...lld:pubmed
pubmed-article:9831130pubmed:authorpubmed-author:LefebvreSSlld:pubmed
pubmed-article:9831130pubmed:authorpubmed-author:GourandLLlld:pubmed
pubmed-article:9831130pubmed:issnTypePrintlld:pubmed
pubmed-article:9831130pubmed:volume59lld:pubmed
pubmed-article:9831130pubmed:ownerNLMlld:pubmed
pubmed-article:9831130pubmed:authorsCompleteYlld:pubmed
pubmed-article:9831130pubmed:pagination751-7lld:pubmed
pubmed-article:9831130pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:9831130pubmed:meshHeadingpubmed-meshheading:9831130-...lld:pubmed
pubmed-article:9831130pubmed:meshHeadingpubmed-meshheading:9831130-...lld:pubmed
pubmed-article:9831130pubmed:meshHeadingpubmed-meshheading:9831130-...lld:pubmed
pubmed-article:9831130pubmed:meshHeadingpubmed-meshheading:9831130-...lld:pubmed
pubmed-article:9831130pubmed:meshHeadingpubmed-meshheading:9831130-...lld:pubmed
pubmed-article:9831130pubmed:meshHeadingpubmed-meshheading:9831130-...lld:pubmed
pubmed-article:9831130pubmed:meshHeadingpubmed-meshheading:9831130-...lld:pubmed
pubmed-article:9831130pubmed:meshHeadingpubmed-meshheading:9831130-...lld:pubmed
pubmed-article:9831130pubmed:meshHeadingpubmed-meshheading:9831130-...lld:pubmed
pubmed-article:9831130pubmed:meshHeadingpubmed-meshheading:9831130-...lld:pubmed
pubmed-article:9831130pubmed:meshHeadingpubmed-meshheading:9831130-...lld:pubmed
pubmed-article:9831130pubmed:meshHeadingpubmed-meshheading:9831130-...lld:pubmed
pubmed-article:9831130pubmed:meshHeadingpubmed-meshheading:9831130-...lld:pubmed
pubmed-article:9831130pubmed:meshHeadingpubmed-meshheading:9831130-...lld:pubmed
pubmed-article:9831130pubmed:meshHeadingpubmed-meshheading:9831130-...lld:pubmed
pubmed-article:9831130pubmed:meshHeadingpubmed-meshheading:9831130-...lld:pubmed
pubmed-article:9831130pubmed:meshHeadingpubmed-meshheading:9831130-...lld:pubmed
pubmed-article:9831130pubmed:meshHeadingpubmed-meshheading:9831130-...lld:pubmed
pubmed-article:9831130pubmed:year1998lld:pubmed
pubmed-article:9831130pubmed:articleTitleSpecific binding of nuclear factors to the HLA-G gene promoter correlates with a lack of HLA-G transcripts in first trimester human fetal liver.lld:pubmed
pubmed-article:9831130pubmed:affiliationCEA, Service de Recherches en Hémato-immunologie, DSV, DRM, Centre Hayem, Hôpital Saint-Louis, Paris, France. moreau@dsvidf.cea.frlld:pubmed
pubmed-article:9831130pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9831130pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9831130lld:pubmed